The Richmond-based pharmaceutical company has begun manufacturing ingredients used in medicines, marking the start of its in-house manufacturing capabilities.
Health care
Bon Secours moving Chester primary care practice to new location
The health system is planning to move its Briggs Road Family Medicine practice about four miles away and rename it Rivers Bend Family Medicine.
Slideshow: Scenes from BizSense’s Future of Healthcare event
Get a glimpse of Wednesday morning’s lively panel discussion, which featured an expert panel that touched on topics from inflation to artificial intelligence.
Scott’s Addition-based sleep therapy clinic launches
The virtual clinic says it’s addressing a deficit in the state’s sleep-therapy resources with an emphasis on a particular treatment for insomnia.
Contractor laying off local employees as HCA brings hospital food service in-house
The food services giant is laying off dozens of local employees as its six-year relationship with one of the region’s biggest health systems comes to a close.
Virginia Physicians for Women planning new office next to St. Francis hospital
CEO Ronnie Milligan said the current location is too small to keep up with demand the organization has at that office, saying it is seeing 2,000 patients a month.
Bon Secours leaving former Commanders training facility for new building at Sauer Center
Bon Secours is planning to open a primary care and sports medicine center, a physical therapy center and an urgent care clinic as part of the latest phase of the Whole Foods-anchored development from Sauer Properties.
New med spa launches with locations in Henrico, Prince George
A group of Richmonders recently opened Vita Pure IV, which offers IV drip therapy and other services, from its locations at 7110 Forest Ave. in western Henrico and 2025 Waterside Road in Prince George.
After Hanover hospital project failed, HCA now planning surgical center for same site
A year after HCA first proposed an ultimately doomed project to build a hospital on Sliding Hill Road in Hanover, the health system is back with a new proposal for the same spot.
Sponsored Content: Retatrutide ‘wiped out’ fat in liver of obese patients
By A.J. Hostetler More than 85% of obese participants with fatty liver disease in a clinical trial of the experimental drug retatrutide reduced their liver fat to the point where they would no longer be classified as having fatty liver disease, according to the Virginia Commonwealth University hepatologist leading the sub-study. Arun Sanyal, M.D., director… Read more »